Phosphodiesterase type IV inhibitors in the treatment of multiple sclerosis

Journal of Molecular Medicine

Volumn 75, Issue 2, 1997, Pages 95-102

  Dinter, Harald ^a   Onuffer, James ^a   Faulds, Daryl ^a   Perez, H Daniel ^a  

^a BAYER AG   (Germany)

Author keywords

experimental allergic encephalomyelitis; inflammation; multiple sclerosis; phosphodiesterase type IV; rolipram

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR;

DRUG EFFICACY; GENE EXPRESSION; HUMAN; INFLAMMATION; MONOCYTE; MULTIPLE SCLEROSIS; NONHUMAN; REVIEW; T LYMPHOCYTE;

ANIMALS; CYCLIC AMP; CYTOKINES; GENE EXPRESSION; HUMANS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED LEW; T-LYMPHOCYTES;

EID: 0030895448     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050094     Document Type: Review

References (70)

1. Prineas JW, Barnard RO, Rovesz, T. Kwon EE, Sharer L, Cho E-S (1993) Multiple sclerosis. Pathology of recurrent lessions. Brain 116:681-693
2. Ozawa K, Suchanek G, Breitschopf H, Bruck W, Budka H, Jelliger K, Lassmann H (1994) Patterns of oligodendroglia pathology in multiple sclerosis. Brain 117:1311-1322
3. Traugott U, Reinherz EL, Raine CS (1983) Multiple sclerosis: distribution of T-cell subsets within active chronic lesions. Science 219:308-310
4. Hofman FM, von Hanwehr RI, Dinarello CA, Mizel SB, Hinton, D, Merril, JE (1986) Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 136:3239-3245
5. Calder V, Owen S, Watson C, Feldman M, Davidson A (1989) MS: a localized immune disease of the central nervous system. Immunol Today 10:99-103
6. Selmaj K, Raine CS, Canella B, Brosnan CF (1991) Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954
7. Hofman FM, Hinton DR, Johnson K, Merrill JE (1989) Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607-612
8. Woodroofe MN, Cuzner ML (1993) Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. Cytokine 5:583-588
9. Traugott U, Lebon P (1988) Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 84:257-262
10. Hurwitz AA, Lyman WD, Guida MP, Calderon TM, Berman JW (1992) Tumor necrosis factor α induces adhesion molecule expression on human fetal astrocytes. J Exp Med 176:1631-1636
11. Sharief MK, Thompson EJ (1992) In vivo relationship of tumor necrosis factor-α to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 38:27-34
12. Selmaj K, Raine CS (1988) Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346
13. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193-1200
14. Selmaj K, Raine CS, Cross AH (1991) Anti-tumor necrosis factor therapy abrogates autoimmune demyelination. Ann Neurol 30:694-700
15. Selmaj K, Papierz W, Glabinski A, Kohno T (1995) Prevention of chronic relapsing experimental autoimmune encephalomyelitis by soluble tumor necrosis factor receptor I. J Neuroimmunol 56:135-141
16. Semmler J, Wachtel H, Endres S (1993) The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells. Int J Immunopharmac 15:409-413
17. Sommer N, Löschmann P-A, Northoff GH, Weller M, Steinbrecher A, Steinbach JP, Lichtenfels R, Meyermann R, Riethmüller A, Fontana A, Dichgans J, Martin R (1995) The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nature Med 1:244-248
18. Genain CP, Roberts T, Davis RL, Nguyen M-H, Uccelli A, Faulds D, Li Y, Hedgepeth J, Hauser SL (1995) Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor. Proc Natl Acad Sci USA 92:3601-3605
19. Iyengar R (1996) Gating by cyclic AMP: expanded role for an old signaling pathway. Science 271:461-463
20. Beavo JA, Conti M, Heaslip RJ (1994) Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol 46:399-405
21. Thompson WT (1991) Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function. Pharmacol Therapeut 51:13-33
22. Conti M, Nemoz G, Sette C, Vicini E (1995) Recent progress in understanding the hormonal regulation of phosphodiesterases. Endocrine Rev 16:370-389
23. Beavo JA (1988) Multiple isozymes of cyclic nucleotide phosphodiesterase. Advances Second Messenger Phosphoprotein Res 22:1-38
24. Giembyzc MA (1992) Could isozyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem Pharamacol 43: 2041-2051
25. m cyclic AMP phosphodiesterases: a family of related enzymes. In: Beavo J, Houslay MD (eds) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action, vol 2. Wiley, Chichester, pp 243-266
26. Sette C, Vicini E, Conti M (1994) The ratPDE3/IVd phosphodiesterase gene codes for multiple proteins differentially activated by cAMP-dependent protein kinase. J Biol Chem 269: 18271-18274
27. Alvarez R, Sette C, Yang D, Eglen RM, Wilhelm R, Shelton ER, Conti M (1995) Activation and selective inhibition of a cyclic AMP-specific phoshodiesterase, PDE-4D3. Mol Pharmac 48:616-622
28. Luther M, Holmes B, Kassel D, Lenhard J, Hamacher L, Burkhart W, Moyer M, Patel I, Overton L, Hoffmann C, Rocque W (1994) Identification and functional characterization of various phosphorylated forms of human recombinant rolipram sensitive cAMP specific type IV phosphodiesterase. FASEB J 2141:A370 (abstract)
29. Wachtel H, Schneider HH (1986) Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Neuropharmacol 25:1119-1126
30. Schneider HH, Schmiechen R, Brezinski M, Seidler J (1986) Stereospecific binding of the antidepressant rolipram to brain protein structures. Eur J Pharmacol 127:105-115
31. Scheider HH, Yamaguchi M, Andrews JS Stephens DN (1995) Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram. Pharmacol Biochem Behav 50:211-217
32. Thompson WJ, Appleman MM (1971) Multiple cyclic nucleotide phosphodiesterase activities from rat brain. Biochem 10:311-316
33. Engels P, Sullivan M, Müller T, Lübbert H (1995) Specific phosphodiesterase subtype (PDE IV-C). FEBS Lett 358: 305-310
34. Torphy TJ, Stadel JM, Burman M, Cieslinski LB, McLaughlin MM, White JR, Livi GP (1992) Coexpression of human cAMP-specific phosphodiesterase activity and high affinity rolipram binding in yeast. J Biol Chem 267:1798-1804
35. Pillai R, Kytle K, Reyes A, Colicelli J (1993) Use of a yeast expression system for the isolation and analysis of drug-resistant mutants of a mammalian phosphodiesterase. Proc Natl Acad Sci USA 90:11970-11974
36. A-h6,1). Cell Signal 6:793-812
37. Bolger G, Michaeli T, Martins T, St. John T, Steiner B, Rodgers L, Riggs M, Wigler M, Ferguson K (1993) A family of human phosphodiesterases homologues to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs. Mol Cell Biol 13: 6558-6571
38. Monaco L, Vicini E, Conti M (1994) Structure of two rat genes coding for closely related rolipram-sensitive cAMP phosphodiesterases. J Biol Chem 269:347-357
39. D). Gene 138:253-256
40. m, rolipram-sensitive, cAMP-specific phosphodiesterase from human brain. J Biol Chem 268: 6470-6476
41. Obernolte R, Bhakta S, Alvarez R, Bach C, Zuppan P, Mulkins M, Jarnagin K, Shelton ER (1993) The cDNA of a human lymphocyte cyclic-AMP phosphodiesterase (PDE IV) reveals a multigene family. Gene 129:239-247
42. Swinnen JV, Joseph DR, Conti M (1989) Molecular cloning of rat homologues of the Drosophila melanogaster dunce cAMP phosphodiesterase: evidence for a family of genes. Proc Natl Acad Sci USA 86:5325-5329
43. Swinnen JV, Joseph DR, Conti M (1989) The mRNA encoding a high-affinity cAMP phosphodiesterase is regulated by hormones and cAMP. Proc Natl Acad Sci USA 86:197-8201
44. m, rolipram-sensitive cyclic AMP phosphodiesterase. Mol Cell Biol 10:2678-2686
45. Engels P, Sullivan M, Mueller T, Luebbert H (1995) Molecular cloning and functional expression in yeast of a human cAMP-specific phosphodiesterase subtype (PDE IV-C). FEBS Lett 358:305-310
46. 2) in brain: selective localisation in membrane and cytosolic compartments and differential expression in various brain regions. Biochem J 304:399-406
47. Schneider HH, Pahlke G, Schmiechen R (1997) Sensitivity of a cAMP PDE to rolipram in different organs. In: Heilmeyer LMG (ed) Signal transduction and protein phosphorylation. NATO AS Series A New York. London, vol 135, pp 81-85
48. 2. J Biol Chem 270:23598-23604
49. Vergehse MW, McConnell RT, Lenhard JM, Hamacher L, Jin SLC (1995) Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells. Mol Pharmacol 47:1164-1171
50. Reeves ML, England PJ (1990) Cardiac phosphodiesterases and the functional effects of selective inhibitors. In: Beavo J, Houslay MD (eds) Cyclic nucleotide phosphodiesterases: structure, regulation and drug action. Wiley, vol 2. Chichester, pp 299-316
51. Weishaar RE, Burrows SD, Kobylarz DC, Quade MM, Evans DB (1986) Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets, Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents. Biochem Pharmacol 35:787-800
52. Raeburn D, Underwood SL, Lewis SA, Woodman VR, Battram CH, Tomkinson A, Sharma S, Jordan R, Souness JE, Webber SE, Karlsson JA (1994) Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol 113:1423-1431
53. De Boer J, Philpott AJ, VanAmsterdam RGM, Shahid M, Zaagsma J, Nicholson CD (1991) Human bronchial cyclic nucleotide phosphodiesterase isozymes: biochemical and pharmacological analysis using selective inhibitors. Br J Pharmacol 106:1028-1034
54. Qian Y, Naline E, Karlsson J-A, Raeburn D, Ad Venier C (1993) Effects of rolipram and siguazodan on the human isolated bronchus and their interaction with isoprenaline and sodium nitroprusside. Br J Pharmacol 109:774-778
55. m phosphodiesterase from human monocytes. Fed Proc 4:1710
56. Prabhakar U, Lipshutz D, O'Leary Bartus J, Slivjak MJ, Smith III EF, Lee JC, Esser KM (1994) Characterization of cAMP-dependent inhibition or LPS-induced TNF α production by rolipram, a specific phosphodiesterase IV (PDF IV) inhibitor. Int J Ummunopharmac 16:805-816
57. Taffet SM, Singhel KJ, Overholtzer JF, Shurtleff SA, (1989) Regulation of tumor necrosis factor expression in a macrophage-like cell line by lipopolysaccaride and cyclic AMP. Cell Immunol 120:291-300
58. Stricter RM, Remick DG, Ward PA, Spengler RN, Lynch JP, Larrick J, Kunkel SL (1988) Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Comm 155:1230-1236
59. Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G (1995) Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin stimulated macrophages. J Immunol 155:4909-4916
60. Cua DJ, Hinton DR, Stohlman SA (1995) Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. J Immunol 155:4052-4059
61. van der Veen R, Stohlman SA (1993) Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: Roles of interleukin (IL)-4 and -10. J Neuroimmunol 48: 213-220
62. Baron JL, Madri JA, Ruddle NH, Hashim G, Janeway Jr, CA (1993) Surface expression of α integrin by CD4 T cells is required for their entry into brain parenchyma. J Exp Med 177: 57-68
63. + T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16:34-38
64. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS, Shevach EM, Roecken M (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966
65. Novak TJ, Rothenberg EV, (1990) cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc Natl Acad Sci USA 87:9353-9357
66. Munoz E, Zubiaga AM, Merrow M, Sauter NP, Huber BT (1990) Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor mediated activation. J Exp Med 172: 95-103
67. Rott O, Cash E, Fleischer B (1993) Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1-but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats. Eur J Immunol 23:1745-1751
68. Massacesi L, Genain CP, Lee-Parritz D, Canfield D, Hauser SL (1995) Active and passivly induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis. Ann Neurol 37:519-530
69. Aggarwal BB, Kohr WJ (1985) Human tumor necrosis factor. Methods Enzymol 116:441-448
70. Conolly DT, Knight MB, Harakas NK, Wittwer AJ, Feder J (1986) Determination of the number of endothelial cells in culture using an acid phosphatase assay. Anal Biochem 152: 136-140